| Product dosage: 180mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | $3.38 | $101.30 (0%) | 🛒 Add to cart |
| 60 | $2.71 | $202.60 $162.48 (20%) | 🛒 Add to cart |
| 90 | $2.50 | $303.90 $224.66 (26%) | 🛒 Add to cart |
| 120 | $2.37 | $405.19 $284.84 (30%) | 🛒 Add to cart |
| 180 | $2.26 | $607.79 $407.20 (33%) | 🛒 Add to cart |
| 270 | $2.19
Best per pill | $911.69 $591.74 (35%) | 🛒 Add to cart |
| Product dosage: 60mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 60 | $0.82 | $49.14 (0%) | 🛒 Add to cart |
| 90 | $0.78 | $73.72 $70.21 (5%) | 🛒 Add to cart |
| 120 | $0.76 | $98.29 $91.27 (7%) | 🛒 Add to cart |
| 180 | $0.74 | $147.43 $132.39 (10%) | 🛒 Add to cart |
| 270 | $0.72 | $221.15 $195.58 (12%) | 🛒 Add to cart |
| 360 | $0.72
Best per pill | $294.87 $257.76 (13%) | 🛒 Add to cart |
Similar products
More info:
diltiazem
Diltiazem hydrochloride represents one of the most versatile cardiovascular agents in our modern pharmacopeia, a calcium channel blocker with a fascinatingly specific effect profile that makes it particularly valuable in certain clinical scenarios where other agents might fall short. Initially approved for hypertension and angina, its applications have expanded significantly based on its unique electrophysiological properties. The crystalline powder formulation of diltiazem hydrochloride, typically available in immediate-release (30mg, 60mg, 90mg, 120mg), extended-release (120mg, 180mg, 240mg, 300mg, 360mg, 420mg), and injectable forms, demonstrates variable bioavailability depending on the formulation.
Bystolic: Advanced Beta-Blocker Therapy for Hypertension and Cardiovascular Protection - Evidence-Based Review
Bystolic represents one of those interesting cases in cardiovascular pharmacology where we got more than we initially bargained for. When I first started prescribing nebivolol back in 2008, most of us saw it as just another beta-blocker - maybe a bit more cardioselective than metoprolol, but essentially the same mechanism. What we discovered over the subsequent decade fundamentally changed how I approach hypertension management, particularly in complex patients with multiple comorbidities.
Calan: Comprehensive Cardiovascular Protection Through Calcium Channel Blockade - Evidence-Based Review
Calan, known generically as verapamil, represents one of the foundational calcium channel blockers in cardiovascular therapeutics. Initially developed in the 1960s by Knoll AG, this phenylalkylamine derivative has maintained clinical relevance for decades due to its multifaceted mechanism targeting L-type calcium channels. Unlike dihydropyridine agents that predominantly affect vascular smooth muscle, verapamil exhibits significant activity on both cardiac myocytes and nodal tissue, creating a unique therapeutic profile that straddles antianginal, antiarrhythmic, and antihypertensive applications.
Cardizem: Effective Blood Pressure and Heart Rhythm Control - Evidence-Based Review
Cardizem, known generically as diltiazem, is a calcium channel blocker primarily prescribed for managing cardiovascular conditions such as hypertension, angina, and certain arrhythmias. It functions by relaxing blood vessels and reducing heart rate, which helps lower blood pressure and decrease the heart’s oxygen demand. Available in various formulations including immediate-release tablets, extended-release capsules, and intravenous forms, Cardizem is a cornerstone in cardiology due to its efficacy and relatively favorable side effect profile.
colchicine
Colchicine is a plant-derived alkaloid medication originally extracted from the autumn crocus (Colchicum autumnale). For centuries, it’s been a cornerstone therapy for acute gout flares, but its applications have significantly expanded in modern cardiology and rheumatology. It works primarily by inhibiting microtubule polymerization, which disrupts cellular functions in neutrophils and other inflammatory cells. This monograph provides a comprehensive, evidence-based review of colchicine’s pharmacology, clinical applications, and safety profile. 1. Introduction: What is Colchicine?
inderal
Propranolol hydrochloride, marketed under the brand name Inderal, represents one of the foundational beta-blockers in cardiovascular and neurological medicine. As a non-selective beta-adrenergic antagonist, it competitively blocks catecholamine effects at both β1 and β2 adrenergic receptors, producing a wide spectrum of therapeutic actions from heart rate control to anxiety symptom reduction. First synthesized by Sir James Black in 1964, its development marked a turning point in how we approach sympathetic nervous system overactivity.
innopran xl
Propranolol hydrochloride extended-release capsules – that’s the official nomenclature for what most of us just call Innopran XL. It’s a non-selective beta-adrenergic blocking agent, a workhorse in cardiovascular and neurological medicine that’s been around for decades but continues to surprise us in its extended-release formulation. The “XL” denotes its 24-hour controlled-release delivery system, a significant advancement over the immediate-release version many of us trained with. Its core function is straightforward: competitive antagonism of catecholamines at β1- and β2-adrenergic receptors.
Isoptin: Comprehensive Cardiovascular Protection and Rhythm Control - Evidence-Based Review
Isoptin, known generically as verapamil hydrochloride, represents one of the foundational calcium channel blockers in cardiovascular therapeutics. Initially developed in the 1960s by Knoll AG, this phenylalkylamine derivative has maintained clinical relevance through decades of practice due to its unique electrophysiological properties and versatile applications. Unlike dihydropyridine calcium channel blockers that predominantly affect vascular smooth muscle, Isoptin exhibits significant activity on both cardiac myocytes and vascular tissues, creating a distinct therapeutic niche.
Lopressor: Targeted Cardiovascular Protection Through Beta-Blockade - Evidence-Based Review
Lopressor, known generically as metoprolol, is a selective beta-1 adrenergic receptor blocker belonging to the class of medications called beta-blockers. It’s primarily prescribed for managing cardiovascular conditions including hypertension, angina pectoris, and heart failure, and for secondary prevention after myocardial infarction. What makes Lopressor particularly valuable in clinical practice is its cardioselective properties, meaning it preferentially blocks beta-1 receptors in the heart while having less effect on beta-2 receptors in the lungs, though this selectivity is dose-dependent.